Loading...
XNAS
NATR
Market cap382mUSD
Dec 05, Last price  
21.88USD
1D
3.35%
1Q
27.65%
Jan 2017
45.87%
IPO
397.27%
Name

Natures Sunshine Products Inc

Chart & Performance

D1W1MN
XNAS:NATR chart
P/E
49.74
P/S
0.84
EPS
0.44
Div Yield, %
—
Shrs. gr., 5y
-1.09%
Rev. gr., 5y
4.64%
Revenues
454m
+2.03%
351,684,000362,222,000366,647,000381,299,000343,023,000349,918,000367,813,000367,468,000378,096,000366,367,000324,705,000341,159,000342,029,000364,810,000362,215,000385,205,000444,084,000421,910,000445,320,000454,364,000
Net income
8m
-48.95%
3,504,000-3,565,000-8,237,000-1,838,0006,115,000-1,233,00017,601,00025,380,00017,609,00010,019,00014,687,0002,139,000-12,942,000-854,0006,765,00021,337,00028,853,000550,00015,076,0007,696,000
CFO
25m
-38.64%
17,012,00014,252,00012,832,000772,000927,00016,150,0003,908,00026,651,00029,378,00014,182,00010,162,0003,417,00010,524,00021,833,0008,545,00037,659,00034,608,000710,00041,226,00025,298,000
Dividend
Mar 26, 20211 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.
URL
https://www.naturessunshine.com/us/
IPO date
Jun 25, 2009
Employees
800
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT